vs
Side-by-side financial comparison of Allegion (ALLE) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.4× Allegion). Allegion runs the higher net margin — 13.4% vs 4.4%, a 8.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 9.7%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 3.5%).
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers, controls, and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors and door systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facili...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
ALLE vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $138.1M | $66.5M |
| Gross Margin | 44.0% | 90.5% |
| Operating Margin | 18.9% | 12.4% |
| Net Margin | 13.4% | 4.4% |
| Revenue YoY | 9.7% | 32.8% |
| Net Profit YoY | -6.8% | 143.8% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $941.9M | $1.1B | ||
| Q4 24 | $945.6M | $1.1B | ||
| Q3 24 | $967.1M | $1.0B | ||
| Q2 24 | $965.6M | $929.2M |
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $66.5M | ||
| Q3 25 | $188.4M | $124.8M | ||
| Q2 25 | $159.7M | $94.3M | ||
| Q1 25 | $148.2M | $1.3M | ||
| Q4 24 | $144.1M | $-151.9M | ||
| Q3 24 | $174.2M | $-121.3M | ||
| Q2 24 | $155.4M | $-120.4M |
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 90.5% | ||
| Q3 25 | 45.8% | 86.1% | ||
| Q2 25 | 45.6% | 87.5% | ||
| Q1 25 | 44.9% | 85.2% | ||
| Q4 24 | 44.1% | 85.8% | ||
| Q3 24 | 44.7% | 83.0% | ||
| Q2 24 | 44.4% | 85.1% |
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 12.4% | ||
| Q3 25 | 21.8% | 11.5% | ||
| Q2 25 | 21.5% | 6.7% | ||
| Q1 25 | 20.9% | 1.0% | ||
| Q4 24 | 19.5% | -7.0% | ||
| Q3 24 | 22.2% | -12.0% | ||
| Q2 24 | 21.6% | -11.5% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 4.4% | ||
| Q3 25 | 17.6% | 8.8% | ||
| Q2 25 | 15.6% | 7.2% | ||
| Q1 25 | 15.7% | 0.1% | ||
| Q4 24 | 15.2% | -13.5% | ||
| Q3 24 | 18.0% | -12.1% | ||
| Q2 24 | 16.1% | -13.0% |
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $0.05 | ||
| Q3 25 | $2.18 | $0.08 | ||
| Q2 25 | $1.85 | $0.06 | ||
| Q1 25 | $1.71 | $0.00 | ||
| Q4 24 | $1.65 | $-0.10 | ||
| Q3 24 | $1.99 | $-0.09 | ||
| Q2 24 | $1.77 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $308.9M | $4.5B |
| Total DebtLower is stronger | $2.0B | $836.4M |
| Stockholders' EquityBook value | $2.1B | $4.4B |
| Total Assets | $5.3B | $8.2B |
| Debt / EquityLower = less leverage | 0.97× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $4.5B | ||
| Q3 25 | $302.7M | $4.0B | ||
| Q2 25 | $656.8M | $2.8B | ||
| Q1 25 | $494.5M | $2.5B | ||
| Q4 24 | $503.8M | $2.6B | ||
| Q3 24 | $878.9M | $2.7B | ||
| Q2 24 | $747.5M | $2.6B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $836.4M | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $4.4B | ||
| Q3 25 | $1.9B | $4.1B | ||
| Q2 25 | $1.8B | $3.8B | ||
| Q1 25 | $1.6B | $3.5B | ||
| Q4 24 | $1.5B | $3.3B | ||
| Q3 24 | $1.6B | $3.4B | ||
| Q2 24 | $1.4B | $3.4B |
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $8.2B | ||
| Q3 25 | $5.2B | $7.6B | ||
| Q2 25 | $4.9B | $6.3B | ||
| Q1 25 | $4.6B | $5.8B | ||
| Q4 24 | $4.5B | $5.9B | ||
| Q3 24 | $5.0B | $5.8B | ||
| Q2 24 | $4.8B | $5.7B |
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 0.19× | ||
| Q3 25 | 1.07× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 1.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $101.3M | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | 2.0% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.73× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $417.3M | ||
| Q3 25 | $229.5M | $402.6M | ||
| Q2 25 | $209.7M | $263.6M | ||
| Q1 25 | $104.5M | $44.1M | ||
| Q4 24 | $219.0M | $75.2M | ||
| Q3 24 | $231.9M | $188.4M | ||
| Q2 24 | $173.0M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $379.8M | ||
| Q3 25 | $209.8M | $354.5M | ||
| Q2 25 | $192.0M | $219.8M | ||
| Q1 25 | $83.4M | $-12.3M | ||
| Q4 24 | $194.9M | $-17.3M | ||
| Q3 24 | $212.0M | $54.7M | ||
| Q2 24 | $152.1M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 25.4% | ||
| Q3 25 | 19.6% | 25.1% | ||
| Q2 25 | 18.8% | 16.7% | ||
| Q1 25 | 8.9% | -1.1% | ||
| Q4 24 | 20.6% | -1.5% | ||
| Q3 24 | 21.9% | 5.5% | ||
| Q2 24 | 15.8% | -22.1% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 2.5% | ||
| Q3 25 | 1.8% | 3.4% | ||
| Q2 25 | 1.7% | 3.3% | ||
| Q1 25 | 2.2% | 5.0% | ||
| Q4 24 | 2.5% | 8.2% | ||
| Q3 24 | 2.1% | 13.3% | ||
| Q2 24 | 2.2% | 11.8% |
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 6.28× | ||
| Q3 25 | 1.22× | 3.22× | ||
| Q2 25 | 1.31× | 2.79× | ||
| Q1 25 | 0.71× | 34.71× | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
ONC
Segment breakdown not available.
